Qiagen Beats Earnings, But Its Expensive Valuation Caps Upside Potential

Company Overview - Qiagen N.V. (NYSE: QGEN) is a biotechnology company that specializes in sample preparation and molecular analysis for diagnostics, applied testing, and research applications [1]. Customer Segments - The majority of Qiagen's customers are derived from its Life Sciences and Molecular Diagnostics segments [1].